AVROBIO Inc. (NASDAQ:AVRO) currently has a daily average trading volume of 2.10M but it saw 2396336 shares traded on Thursday. With a market cap of 54.90M USD, stock’s current market price of $1.15 came falling about -8.73 while comparing to the previous closing price of $1.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.93 and as low as $0.56. In the recent trading on the day, stock has struck highest price mark of $1.31 while lowest mark touched by it was $1.12.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Taking a look at 20-day trading activity of AVROBIO Inc. (AVRO) gives us an average price of $0.8177, while its current price level is -40.41% below from 52-week high level whereas it is 105.36% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9208 while that of 200 days or SMA-200 reads an average of $0.9209. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.58% during that period while stretching the period over a month that decreases to 16.88%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.01 which implies that the stock is in neutral territory.
AVROBIO Inc. (AVRO)’s stock is currently under the radar of 8 analysts who are in consensus at a 12-month price target range of between $2.00 and $6.00 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $2.00 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $6.00. Average price target assigned by them is $3.64 which highlights an upside potential of 68.41% for the stock over that period. And to attain the median price target of $4.00 assigned by those analysts, stock has to add about 71.25% of value to its current levels.
Data by FactSet Research shows that 8 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 1 are advising it as an Overweight. 6 analysts suggested the investors to Buy the stock while 1 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Buy for the stock and that issued by Wall Street to investors is Moderate Buy.
Over the week, AVRO’s stock price is moving 36.90% up while it is 29.21% when we observe its performance for the past one month. Year-to-date it is 61.31% up and over the past year, the stock is showing an upside performance of 36.56%.
The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of -$0.57 beaten by the consensus estimate of -$0.54 for the same. The company is expected to be releasing its next quarterly report in 08/10/2023, for which analysts forecasted an EPS of -$0.17 while estimate for next year EPS is -$1.5. For AVRO, analysts are forecasting an EPS-growth rate of 38.00% for current year and estimate for EPS growth in next year is -5.30%.
Currently, AVROBIO Inc.’s total number of outstanding shares is 44.04M with 2.66% of that held by the insiders while 52.87% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -117.20%. Stock’s beta reads 1.59. Stock has a price to book (P/B) ratio of 0.96. Its return on asset (ROA) is -87.30% on average.
In the most recent quarter, Stichting Pensioenfonds ABP came cutting its stake by -28.89% in the company and now holds 0.3 million or 0.67% of the company’s stake having worth of about 0.29 million.
